Critical Path Institute Names Martha Brumfield CEO The Board of Directors of the Critical Path Institute (C-Path) announced today that Martha Brumfield, Ph.D., has been named interi
C-Path Cosponsors Workshop on Combination Drug Development for Alzheimer’s Disease Combination therapy development has been successful in other life-threatening diseases in part because collaborative approaches we
Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Accelerations Network Dr Carolyn Compton served as planning committee co-chair for the recent Institute of Medicine workshop, “Accelerating the De
Stars Shine at the 2012 AZBIO Awards On Tuesday October 23, 2012 the stars were shining inside the Phoenix Convention Center at the AZBio Awards as our community came
20 Women of Influence who make Tucson better If you felt as if you needed a little more muscle to lift this week’s printed issue of Inside Tucson Business, you can thank
Critical Path Institute Receives Bronze Award From League of American Bicyclists Critical Path Institute (C-Path) announces that it has received a Bronze Bicycle Friendly Business (BFB) award from the League of
FDA Works with Partners to Establish Important Therapeutic Area Data Standards Clarification, November 5, 2012: CFAST is a joint initiative of CDISC and the Critical Path Institute. The FDA and TransCelerate B
Drug Makers Join Efforts in Research Ten of the world’s largest pharmaceutical companies said on Wednesday that they would cooperate on research aimed at acceler
FDA, IMI, and Patient Advocates to Present at CDISC 2012 International Interchange Formal Launch of CFAST – Collaboration between C-Path and CDISC The Clinical Data Interchange Standards Consortium (CDISC) and Critical Path Institute (C-Path) announce the launch of the Coaliti